Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 5015: HERA-CD40L a hexavalent CD40 agonist induces T cell mediated anti-tumor immune response and shows superior activity in direct comparison to benchmark agonistic antibodies

Cancer Res (2019) 79 (13_Supplement): 5015.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Close Modal

or Create an Account

Close Modal
Close Modal